Advancements and Challenges in SMA Newborn Screening

This chapter explores the nationwide implementation of newborn screening for Spinal Muscular Atrophy (SMA) in the U.S. as of January 2024, showcasing community advocacy. It also emphasizes the importance of follow-up diagnostic testing due to the screening's limitations in detecting all cases.